The 2-Minute Rule for QST4
The first conclusion level was the safety and tolerability of sifalimumab. Treatment method-emergent adverse situations (AEs) and really serious AEs (SAEs) and their severity, outcome, and any relationship for the research medication have been recorded from the investigator through the entire research. AEs had been viewed as more likely to be relev